Abstract:Vascular smooth muscle cells (VSMCs) are crucial components of the arterial wall, controlling blood flow and pressure by contracting and relaxing the artery walls. VSMCs can switch from a contractile to a synthetic state, leading to increased proliferation and migratory potential. Epigenetic pathways, including DNA methylation, play a crucial role in regulating VSMC differentiation and phenotypic flexibility. DNA methylation involves attaching a methyl group to the 5' carbon of a cytosine base, which regulates gene expression by interacting with transcription factors. Understanding the key factors influencing VSMC plasticity may help to identify new target molecules for the development of innovative drugs to treat various vascular diseases. This review focuses on DNA methylation pathways in VSMCs, summarizing mechanisms involved in controlling vascular remodeling, which can significantly enhance our understanding of related mechanisms and provide promising therapeutic approaches for complex and multifactorial diseases.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the impact of DNA methylation on the phenotypic transformation of vascular smooth muscle cells (VSMCs). Specifically, the paper focuses on how DNA methylation affects the transformation of VSMCs from the contractile type to the synthetic or proliferative type by regulating gene expression. This process plays a crucial role in various vascular diseases, such as atherosclerosis, pulmonary hypertension, intimal hyperplasia, aortic aneurysm, chronic kidney disease, and diabetes. ### Background of the Paper Vascular smooth muscle cells (VSMCs) are an important part of the arterial wall and control blood flow and blood pressure by contracting and relaxing the arterial wall. VSMCs are highly plastic and can transform from the contractile type to the synthetic type under the stimulation of environmental signals, resulting in enhanced cell proliferation and migration abilities. This phenotypic transformation is particularly important after arterial injury because it participates in the vascular repair process, but excessive phenotypic transformation can lead to abnormal vascular remodeling and then trigger various cardiovascular diseases. ### Research Objectives This article aims to review the role of DNA methylation pathways in VSMCs, especially how these pathways regulate the mechanisms of vascular remodeling. By understanding the role of DNA methylation in the phenotypic transformation of VSMCs, researchers hope to discover new target molecules for the development of innovative drugs to treat various vascular diseases. ### Main Contents 1. **Phenotypic Transformation of VSMCs**: - VSMCs are usually in a quiescent state in the arteries of mature individuals, with a low proliferation rate and a small amount of synthetic activity. - After arterial injury, VSMCs will transform from the contractile type to the synthetic type, manifested as a decrease in the expression of related differentiation genes and an enhancement in the abilities of migration, proliferation, and production of extracellular matrix (ECM). - This phenotypic transformation plays an important role in various cardiovascular diseases such as atherosclerosis, pulmonary hypertension, intimal hyperplasia, and aortic aneurysm. 2. **Mechanisms of DNA Methylation**: - DNA methylation is an important epigenetic modification, mainly occurring at the 5' - carbon position of cytosine to form 5 - methylcytosine (5 - mC), usually occurring on CpG dinucleotides. - DNA methyltransferases (DNMTs) catalyze this process, where DNMT1 is responsible for maintaining the methylation pattern during DNA replication, while DNMT3A and DNMT3B are responsible for new DNA methylation. - Methylation can inhibit gene transcription by recruiting and binding methyl - CpG - binding domain (MBD) proteins such as MeCP2. 3. **Relationship between DNA Methylation and Phenotypic Transformation of VSMCs**: - The role of DNA methylation in the phenotypic transformation of VSMCs is achieved by regulating the expression of key genes. - For example, in atherosclerosis, the differentiation markers of VSMCs are significantly reduced, and the synthetic - type VSMCs invade the lumen in eccentric atherosclerotic lesions, which is related to the change in DNA methylation patterns. - Similarly, in pulmonary hypertension, the change in DNA methylation patterns is closely related to the behavioral transformation of pulmonary artery smooth muscle cells. ### Conclusion By in - depth study of the role of DNA methylation in the phenotypic transformation of VSMCs, the mechanisms of vascular remodeling can be better understood and provide a theoretical basis for the development of new treatment methods for complex multi - factor vascular diseases.

Influence of DNA Methylation on Vascular Smooth Muscle Cell Phenotypic Switching

Inhibition of Polycomb Repressor Complex 2 Ameliorates Neointimal Hyperplasia by Suppressing Trimethylation of H3K27 in Vascular Smooth Muscle Cells.

Methyltransferase Like 3-Mediated N6-methylatidin Methylation Inhibits Vascular Smooth Muscle Cells Phenotype Switching Via Promoting Phosphatidylinositol 3-Kinase Mrna Decay.

Dedifferentiation of Vascular Smooth Muscle Cells Upon Vessel Injury

An overview of potential molecular mechanisms involved in VSMC phenotypic modulation

Role of mitochondrial dynamics and mitophagy of vascular smooth muscle cell proliferation and migration in progression of atherosclerosis

Vascular Smooth Muscle Cells Phenotypic Switching in Cardiovascular Diseases

SUV39H1 mediated regulation of KLF4 and KDM4A coordinate smooth muscle cell phenotypic plasticity

How vascular smooth muscle cell phenotype switching contributes to vascular disease

Matrix Stiffness Determines the Phenotype of Vascular Smooth Muscle Cell in Vitro and in Vivo: Role of DNA Methyltransferase 1

Roles and Mechanisms of DNA Methylation in Vascular Aging and Related Diseases

SWI/SNF Complex in Vascular Smooth Muscle Cells and Its Implications in Cardiovascular Pathologies

Non-coding RNAs: key regulators of smooth muscle cell fate in vascular disease

Geometric Constraints Regulate Energy Metabolism and Cellular Contractility in Vascular Smooth Muscle Cells by Coordinating Mitochondrial DNA Methylation

Histone methylation and vascular biology

An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis

Hypermethylation of Mitochondrial DNA in Vascular Smooth Muscle Cells Impairs Cell Contractility.

Epigenetic Mechanism in Regulation of Endothelial Function by Disturbed Flow: Induction of DNA Hypermethylation by DNMT1

Differentiation And Application Of Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells

Phenotypic switching of vascular smooth muscle cells in atherosclerosis, hypertension, and aortic dissection

Epigenetic Regulation of Vascular Smooth Muscle Cells by Histone H3 Lysine 9 Dimethylation Attenuates Target Gene-Induction by Inflammatory Signaling